Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Avanos Medical (AVNS) EPS (Basic) (2016 - 2025)

Avanos Medical's EPS (Basic) history spans 11 years, with the latest figure at $0.01 for Q3 2024.

  • For Q3 2024, EPS (Basic) rose 100.78% year-over-year to $0.01; the TTM value through Sep 2024 reached $1.37, up 176.11%, while the annual FY2023 figure was -$0.21, 145.65% down from the prior year.
  • EPS (Basic) for Q3 2024 was $0.01 at Avanos Medical, down from $0.04 in the prior quarter.
  • Across five years, EPS (Basic) topped out at $1.34 in Q4 2023 and bottomed at -$1.29 in Q3 2023.
  • The 5-year median for EPS (Basic) is $0.01 (2024), against an average of -$0.02.
  • The largest annual shift saw EPS (Basic) plummeted 758.33% in 2020 before it soared 1433.33% in 2021.
  • A 5-year view of EPS (Basic) shows it stood at -$1.03 in 2020, then surged by 123.3% to $0.24 in 2021, then tumbled by 204.17% to -$0.25 in 2022, then skyrocketed by 636.0% to $1.34 in 2023, then crashed by 99.25% to $0.01 in 2024.
  • Per Business Quant, the three most recent readings for AVNS's EPS (Basic) are $0.01 (Q3 2024), $0.04 (Q2 2024), and -$0.02 (Q1 2024).